Characterization of rpoB mutations in rifampicin-resistant Mycobacterium tuberculosis isolated in China

Tuberculosis

Volumn 82, Issue 2-3, 2002, Pages 79-83

  Huang, Hairong ^a   Jin, Qi ^b   Ma, Yu ^a   Chen, Xi ^a   Zhuang, Yuhui ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b National Laboratory of Molecular Virology and Genetic Engineering   (China)

^c 309TH HOSPITAL OF PLA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATE; CHINA; CODON; MUTATION RATE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0036394217     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1054/tube.2002.0326     Document Type: Article

References (18)

1. Dye C, Scheele S, Dolin P et al. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282:677-686.
2. Ramaswamy S, Musser J M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 1998; 79: 3-29.
3. National technic steering group of the epidemiological sampling survey for tuberculosis (China). Report on fourth national epidemiological sampling survey of tuberculosis. Clin J Tuberc Respir Dis 2002; 25: 3-7
4. Li Qun, Wang Xiaomeng, He Haibo et al. Report on surveillance sponsored by WHO on tuberculosis drug-resistance in Zhejiang province. Clin J Tuberc Respir Dis 2000; 23: 715-717.
5. Marttuka GJ, Soini H, Vyshneveskiy B et al. Rapid detection of rifampicin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 1998; 30: 129-132.
6. Watterson SA, Wilson S, Yates MA et al. Comparison of three molecular assays for rapid detection of rifampicin resistance in Mycobacterium tuberculosis. J Clin Microbiol 1998; 36: 1969-1973.
7. Gingeras TR, Ghandour G, Wang E et al. Simultaneous genotyping and species identification using hybridization pattern recognition analysis of genetic mycobacterium DNA arrays. Genome Res 1998; 8: 435-8448.
8. Telenti A, Imboden P, Marchesi F et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 1993; 341: 647-650.
9. Williams DL, Waguespack C, Eisenach K et al. Characterization of rifampicin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 1994; 38: 2380-2386.
10. Ohno H, Koga H, Kohno S et al. Relationship between rifampicin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother 1996; 40: 1053-1056.
11. Kapur V, Li L-L, Iordanescu S et al. Characterization by automated DNA sequencing of mutations in the gene(rpoB) encoding the RNA polymerase β subunit in rifampicin-resistant Mycobacterium tuberculosis strains from New York City and Texas. J Clin Microbiol 1994; 32: 1095-1098.
12. Caugant D A, Sandven P, Eng J et al. Detection of rifampicin resistance among isolates of Mycobacterium tuberculosis from Mozambique. Microbial Drug Resist 1995; 4: 321-326.
13. Rinder H, Dobner P, Feldmann K et al. Disequilibria in the distribution of rpoB alleles in rifampicin-resistant M. Tuberculosis isolates from Germany and Sierra Leone. Microbial Drug Resist 1997; 3: 195-197.
14. Pozzi G, Meloni M, Iona E et al. rpoB mutation in multidrug-resistant strains of Mycobacterium tuberculosis isolated in Italy. J Clin Microbiol 1999; 37: 1197-1199.
15. Matsiota-Bernard P, Vrioni G, Marinis E. Characterization of rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Greece. J Clin Microbiol 1998; 36: 20-23.
16. Heep M, Brandstatter B, Rieger U et al. Frequency of rpoB mutations inside and outside the cluster I region in rifampicin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2001; 39: 107-110.
17. Ouans S, Venter H, Dabbs E R. Ribosylative inactivation of rifampicin by Mycobacterium smegmatis is principal contributor to its low susceptibility to this antibiotic. Antimicrob Agents Chemother 1997; 41: 2456-2460.
18. Tanaka Y, Yazawa K, Dabbs E R et al. Different rifampicin inactivation mechanisms in Nocardia and related taxa. Microbiol Immunol 1996; 40: 1-4.